John Kollins
Chief Operating Officer chez BioSpace, Inc. (Iowa)
Profil
John A.
Kollins was the founder of Satsuma Pharmaceuticals, Inc. (founded in 2016) where he held the title of President, Chief Executive Officer & Director from 2016 to 2023.
He is currently working as a Director at Symphony ViDA, Inc., Cyrano Therapeutics, Inc., and BioSpace, Inc. (Iowa).
In his former positions, he served as the Chief Executive Officer & Director at Oncotelic Therapeutics, Inc. from 2007 to 2009, Managing Director at Parnassus Advisors, LLC from 2009 to 2012, Product Manager at Immunex Corp., Chief Business Officer at Athena Neurosciences LLC from 2012 to 2014, Vice President-Business Development at Renovis, Inc. from 2003 to 2004, Chief Business Officer at Elan Pharmaceuticals, LLC from 2012 to 2014, Vice President-Business Development at SurroMed, Inc. from 2000 to 2002, Chief Business Officer at CovX Research LLC from 2004 to 2005, and Chief Business Officer & Senior Vice President at Transcept Pharma, Inc. from 2012 to 2014.
Mr. Kollins completed his undergraduate degree at Duke University and holds an MBA from the University of Virginia Darden School of Business.
Postes actifs de John Kollins
Sociétés | Poste | Début |
---|---|---|
Symphony ViDA, Inc.
Symphony ViDA, Inc. Pharmaceuticals: MajorHealth Technology Symphony ViDA, Inc. develops and manufactures biopharmaceutical drugs. Its products are used to treat the multiple forms of cancer and neovascular diseases of the eye. The company was founded in October 2008 and is headquartered in Rockville, MD. | Director/Board Member | - |
BioSpace, Inc. (Iowa)
BioSpace, Inc. (Iowa) Internet Software/ServicesTechnology Services BioSpace, Inc. operates as an online community for industry news and careers for life science professionals. It offers online job board, daily biotech news feeds, and community features connect recruiters, job seekers. The company was founded in March 1995 and is headquartered in Urbandale, IA. | Chief Operating Officer | 25/03/2009 |
Cyrano Therapeutics, Inc.
Cyrano Therapeutics, Inc. Medical SpecialtiesHealth Technology Cyrano Therapeutics, Inc. is a clinical stage regenerative medicine company based in Delray Beach, FL. Cyrano Therapeutics is developing a novel therapy to restore smell and flavor function, with a focus on chronic smell and flavor loss caused by influenza, allergic rhinitis, traumatic brain injury, and COVID-19. The company raised a $12.80m series A financing in December 2020 led by Remiges Ventures and Ventures. The chronic loss of smell and flavor is a condition affecting at least 5% of the population with a similar incidence in and. The company was founded by Robert I. Henkin and Richard Geoffrion, with Richard Geoffrion serving as the CEO since incorporation. | Director/Board Member | 09/11/2021 |
Anciens postes connus de John Kollins
Sociétés | Poste | Fin |
---|---|---|
SATSUMA PHARMACEUTICALS, INC. | Founder | 08/06/2023 |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | Corporate Officer/Principal | 01/10/2014 |
Athena Neurosciences LLC
Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Athena Neurosciences LLC operates as a research-based pharmaceutical company committed to the field of neurology. It develops therapeutic and diagnostic products. The company was founded by David Rowley-Jones, Larry C. Fritz, and Larry A. Bock in 1986 and is headquartered in Allegan, MI. | Corporate Officer/Principal | 01/10/2014 |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/10/2014 |
Parnassus Advisors, LLC | Corporate Officer/Principal | 01/05/2012 |
Formation de John Kollins
Duke University | Undergraduate Degree |
University of Virginia Darden School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ONCOTELIC THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 12 |
---|---|
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
Athena Neurosciences LLC
Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Athena Neurosciences LLC operates as a research-based pharmaceutical company committed to the field of neurology. It develops therapeutic and diagnostic products. The company was founded by David Rowley-Jones, Larry C. Fritz, and Larry A. Bock in 1986 and is headquartered in Allegan, MI. | Commercial Services |
BioSpace, Inc. (Iowa)
BioSpace, Inc. (Iowa) Internet Software/ServicesTechnology Services BioSpace, Inc. operates as an online community for industry news and careers for life science professionals. It offers online job board, daily biotech news feeds, and community features connect recruiters, job seekers. The company was founded in March 1995 and is headquartered in Urbandale, IA. | Technology Services |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Health Technology |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
SurroMed, Inc.
SurroMed, Inc. Miscellaneous Commercial ServicesCommercial Services SurroMed, Inc. provides pharmaceutical research. It focuses on discovering & applying biomarkers to improve the drug discovery and development process and enable the precise diagnosis and personalized treatment of disease. The company's research process yields biological markers and information that enable accelerated, cost-efficient discovery and development of new therapeutic products, as well as development of diagnostic tests for early disease detection, disease staging, patient stratification, guiding and monitoring therapy. SurroMed was founded in 1997 and is located in Menlo Park, CA. | Commercial Services |
CovX Research LLC
CovX Research LLC BiotechnologyHealth Technology Part of Pfizer Inc., CovX Research LLC is a private company that manufactures biotherapeutics and medical products. The company is based in San Diego, CA. The company was founded by Richard Alan Lerner, Carlos F. Barbas. CovX Research was acquired by Pfizer Inc. from Tavistock Life Sciences Co. on January 31, 2008 for $230 million. | Health Technology |
Symphony ViDA, Inc.
Symphony ViDA, Inc. Pharmaceuticals: MajorHealth Technology Symphony ViDA, Inc. develops and manufactures biopharmaceutical drugs. Its products are used to treat the multiple forms of cancer and neovascular diseases of the eye. The company was founded in October 2008 and is headquartered in Rockville, MD. | Health Technology |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | Health Technology |
Satsuma Pharmaceuticals, Inc.
Satsuma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraines. Its product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, or DHE, which is designed to be self-administered with a proprietary pre-filled, single-use, nasal delivery device. The company was founded by John Kollins on June 21, 2016 and is headquartered in Durham, NC. | Health Technology |
Parnassus Advisors, LLC | |
Cyrano Therapeutics, Inc.
Cyrano Therapeutics, Inc. Medical SpecialtiesHealth Technology Cyrano Therapeutics, Inc. is a clinical stage regenerative medicine company based in Delray Beach, FL. Cyrano Therapeutics is developing a novel therapy to restore smell and flavor function, with a focus on chronic smell and flavor loss caused by influenza, allergic rhinitis, traumatic brain injury, and COVID-19. The company raised a $12.80m series A financing in December 2020 led by Remiges Ventures and Ventures. The chronic loss of smell and flavor is a condition affecting at least 5% of the population with a similar incidence in and. The company was founded by Robert I. Henkin and Richard Geoffrion, with Richard Geoffrion serving as the CEO since incorporation. | Health Technology |